LF
ABBV icon

Lantz Financial’s AbbVie ABBV Stock Holding History

Lantz Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.06M Buy
8,202
+555
+7% +$119K 0.38% 75
2026
Q1 		$1.66M Buy
7,647
+89
+1% +$19.7K 0.34% 80
2025
Q4 		$1.73M Sell
7,558
-175
-2% -$39.9K 0.36% 79
2025
Q3 		$1.79M Buy
7,733
+463
+6% +$94.3K 0.4% 71
2025
Q2 		$1.35M Buy
7,270
+269
+4% +$50K 0.34% 85
2025
Q1 		$1.47M Buy
7,001
+340
+5% +$66.1K 0.4% 77
2024
Q4 		$1.18M Buy
6,661
+210
+3% +$38.6K 0.32% 82
2024
Q3 		$1.27M Buy
6,451
+148
+2% +$27.6K 0.34% 79
2024
Q2 		$1.08M Sell
6,303
-247
-4% -$40.9K 0.34% 85
2024
Q1 		$1.19M Sell
6,550
-1,031
-14% -$178K 0.38% 76
2023
Q4 		$1.17M Buy
7,581
+876
+13% +$128K 0.42% 73
2023
Q3 		$999K Buy
6,705
+13
+0.2% +$1.91K 0.4% 70
2023
Q2 		$902K Buy
6,692
+40
+0.6% +$5.87K 0.35% 78
2023
Q1 		$1.06M Buy
6,652
+2,567
+63% +$392K 0.44% 71
2022
Q4 		$660K Buy
4,085
+40
+1% +$6.13K 0.3% 85
2022
Q3 		$543K Buy
4,045
+20
+0.5% +$2.87K 0.28% 84
2022
Q2 		$616K Sell
4,025
-615
-13% -$94K 0.28% 85
2022
Q1 		$752K Sell
4,640
-303
-6% -$44K 0.31% 84
2021
Q4 		$669K Buy
4,943
+329
+7% +$38.9K 0.31% 81
2021
Q3 		$498K Sell
4,614
-39
-0.8% -$4.46K 0.26% 92
2021
Q2 		$524K Buy
4,653
+651
+16% +$73.3K 0.27% 87
2021
Q1 		$433K Buy
4,002
+218
+6% +$23.3K 0.25% 81
2020
Q4 		$405K Sell
3,784
-12,269
-76% -$1.18M 0.25% 80
2020
Q3 		$1.41M Sell
16,053
-49
-0.3% -$4.61K 0.95% 31
2020
Q2 		$1.58M Sell
16,102
-224
-1% -$19.7K 1.14% 21
2020
Q1 		$1.24M Buy
16,326
+13,028
+395% +$1.11M 0.97% 27
2019
Q4 		$292K Buy
3,298
+118
+4% +$9.8K 0.17% 111
2019
Q3 		$229K Buy
3,180
+56
+2% +$3.84K 0.15% 114
2019
Q2 		$232K Buy
3,124
+236
+8% +$18.6K 0.16% 113
2019
Q1 		$233K Buy
+2,888
New +$236K 0.17% 104

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lantz Financial's ABBV Position: Q2 2026 in Review

Lantz Financial increased its AbbVie (ABBV) stake by 7.3% in Q2 2026, buying an estimated $119K and bringing the position to 8,202 shares worth $2.06M. The position accounts for 0.38% of the portfolio, ranked #75.

Lantz Financial first reported a position in ABBV in Q1 2019 and has held it in 30 quarters since. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Lantz Financial held 8,202 shares of AbbVie worth $2.06M as of Q2 2026.
  • Lantz Financial bought 555 AbbVie shares in Q2 2026, an estimated $119K.
  • AbbVie made up 0.38% of Lantz Financial's portfolio in Q2 2026, its #75 holding.
  • Lantz Financial first reported a position in AbbVie in Q1 2019 and has held it in 30 quarters since.
  • 2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lantz Financial's 13F filing for Q2 2026, filed 9 Jul 2026.